Why the study?
Does indapamide sustained-release with optional perindopril reduce mortality and cardiovascular events in hypertensive patients aged 80 and over?
Does indapamide sustained-release with optional perindopril reduce mortality and cardiovascular events in hypertensive patients aged 80 and over?
Blood pressure-lowering treatment with indapamide and optional perindopril provides consistent mortality and cardiovascular benefits across subgroups of hypertensive patients aged 80 and older.
No takes yet. Share an insight, caveat, or question.
Supports indapamide ± perindopril for hypertension in patients ≥80 years; confirms mortality and CV risk reduction in this population.
Beckett et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: